There is a significant overlap between ALS and FTD, and major heterogeneity within each, obstructing the development of new therapies. We now have an international dataset of thousands of patients, enabling us to study the clinical, genetic, epigenetic basis of ALS and FTD, to define the heterogeneity and overlap more precisely using biology, and therefore enabling the development of drugs targeted at specific pathways in specific groups of people. The primary aim is to develop a biological classification of ALS and FTD subtypes to enable targeted drug design for precision medicine.
Applications must be submitted via the King’s College London on-line application system.
Employer: King’s College London
Location: London, England
Conditions: ALS, FTD
Job posted: April 6th, 2019
Applications close: May 1st, 2019